Stocktwits on MSN
XAIR stock more than doubled today — what’s driving the rally?
XTL will acquire NeuroNOS for 19.9% of its issued share capital, $1 million in cash, and milestone-based contingent payments ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...
Over the past half century, researchers have established that birds evolved from dinosaurs: specifically, the theropods, the ...
This Somerville biotech company is gearing up to lay off more than 80 employees in Massachusetts this year. Here's what we ...
A team of researchers led by bioengineer Shaochen Chen will use 3D printing techniques to shape stem cells produced by local firm Allele Biotechnology ...
Dynavax said its board determined the undisclosed bidder's offer was unlikely to lead to a superior proposal to Sanofi's bid. There was substantial risk of Sanofi withdrawing from discussions and ...
Investors poured into a room at #JPM26 to see how Revolution Medicines' CEO would dance around questions they knew he ...
Sabah Öney, President and Chief Executive Officer of Dispatch Bio joins Fred Hutch Board of Directors, bringing expertise in biotechnology leadership and innovation.
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.
An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results